Fresenius Medical Care AG (FMS) Receivables - Other (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Receivables - Other for 17 consecutive years, with $144.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Receivables - Other rose 24.3% year-over-year to $144.7 million; the TTM figure through Dec 2025 stood at $144.7 million (up 24.3% YoY), while the FY2025 annual figure was $144.7 million, up 24.3% from the prior year.
• Receivables - Other came in at $144.7 million for Q4 2025 at Fresenius Medical Care AG, up from $38.6 million in the prior quarter.
• The five-year high for Receivables - Other was $250.5 million in Q4 2023, with the low at -$34.7 million in Q3 2021.
• Average Receivables - Other over 5 years is $75.8 million, with a median of $55.0 million recorded in 2023.
• Across the five-year window, Receivables - Other slumped 314.08% in 2022 and soared 368.26% in 2023, its largest moves.
• Year by year, Receivables - Other stood at $130.2 million in 2021, then soared by 55.55% to $202.6 million in 2022, then rose by 23.68% to $250.5 million in 2023, then tumbled by 53.54% to $116.4 million in 2024, then climbed by 24.3% to $144.7 million in 2025.
• According to Business Quant data, Receivables - Other over the past three periods registered $144.7 million, $38.6 million, and $4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.